Buy or Sell Inovio Stock? Before answering whether you'd buy Inovio stock, it's first important to understand what's going on with coronavirus drug and vaccine development. Inovio didn't report any new developments. nodes[i].dataset.subscription : nodes[i].getAttribute('data-subscription'); if(status ==='true') {nodes[i].checked = true;}}};var nodes = document.querySelectorAll('#form1783 select[data-value]'); if (nodes) { for (var i = 0; i < nodes.length; i++) { var node = nodes[i]; var selectedValue = node.dataset ? The big risk here, compared to other companies, is that they need a delivery system, so they have a machine that injects the DNA into your cells. Use the Zacks Rank and Style Scores to find out is INO is right for your portfolio. This doesn't mean we expect a selloff for $INO in coming sessions, or that it may not climb higher. Even though Inovio is small, it’s still very much in the thick of the race to develop a COVID-19 vaccine. Investors are encouraged to buy a stock when it tops a buy point and is less than 5% extended from that entry. The biotech announced on Monday that its experimental vaccine mRNA-1273 is ready to begin testing in humans. Moderna is another leader in the race to fight the coronavirus. Company-31.83%. Friday, August 7, 2020 | MarketBeat Staff. 2 analysts 25.00%. var dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /(^[A-Z0-9!#$%&'\*\+\-\/=\?\^_`\{\|\}~][A-Z0-9!#$%&'\*\+\-\/=\?\^_`\{\|\}~\.]{0,62}@(([A-Z0-9](?:[A-Z0-9\-]{0,61}[A-Z0-9])?)(\.[A-Z0-9](?:[A-Z0-9\-]{0,61}[A-Z0-9])? You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Use the Zacks Rank and Style Scores to find out is REGN is right for your portfolio. The Inovio Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity more... Analyst Ratings. INOVIO PHARMACEUTICALS IN THE NEWS | SHORTS HATE IT & INVESTORS LOVE IT! Should you buy Inovio stock during the coronavirus market crash? Since May 20, INO stock is down over 10%, and … Investors should avoid INO stock and buy MRNA stock instead on weakness because Moderna's credentials are much more impressive at this point. Investors should avoid INO stock and buy MRNA stock instead on weakness because Moderna's credentials are much more impressive at this point. Image source: Getty Images. To make a long story short, no, INO stock isn't a buy right now based on technical analysis or its revenue and profitability. On the other hand, systematic risk is the risk that Inovio Pharmaceuticals stock's price will be affected by overall stock market movements and cannot be diversified away. Use the Zacks Rank and Style Scores to find out is REGN is right for your portfolio. I would like to receive Nasdaq communications related to Products, Industry News and Events.You can always change your preferences or unsubscribe and your contact information is covered by our Privacy Policy. 1 analysts 12.50%. Is Inovio Stock A Buy Now? The biotech should also have milestones on the way for its other experimental vaccines. Shares of Inovio Pharmaceuticals (NASDAQ:INO) skyrocketed in January with initial worries about the coronavirus outbreak in China. Inovio Pharmaceuticals employs 190 staff and has a trailing 12-month revenue of around USD$2.7 million. According to TipRanks, the consensus on Wall Street is that INO stock is a “hold” for investors. Inovio stock isn't forming a definitive chart pattern. It comes down to how you feel about the results of this Phase 1 trial. Inovio Pharmaceuticals is easily one of the most volatile stocks on the market right now. Should I buy Inovio Pharmaceuticals, Inc. (INO)? Airbnb Stock IPO Is Set to Soar 200%. Should I buy Barclays Plc (BCS)? Should Investors Buy Inovio for Its Coronavirus Vaccine? Industry. So I think that's the biggest risk with Inovio. Inovio should have news about INO-4800 well before then. However, there's no guarantee that any of them will pan out. However, the stock gave up most of those gains over the next few weeks. Enter up to 25 symbols separated by spaces. Before answering whether you'd buy Inovio stock, it's first important to understand what's going on with coronavirus drug and vaccine development. Market-8.22%. node.dataset.value : node.getAttribute('data-value'); if (selectedValue) { for (var j = 0; j < node.options.length; j++) { if(node.options[j].value === selectedValue) { node.options[j].selected = 'selected';break;}}}}}, Do Not Sell My Personal Information (CA Residents Only). Like cervical dysplasia, RRP is caused by human papillomavirus (HPV) infections. Simply, it doesn't match our recommended trading systems Should I sell Inovio Pharmaceuticals stock? How to buy shares in Inovio … In this video from Motley Fool Live recorded on Dec. 7, Corinne Cardina, bureau chief of healthcare and cannabis, and Fool.com contributor Brian Orelli discuss the issues and where Inovio is in the development of its vaccine candidate. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market. 40 Finance 3,166 views. Inovio Pharmaceuticals Inc (INO) stock is trading at $20.41 as of 3:02 PM on Monday, Aug 3, an increase of $0.97, or 4.99% from the previous closing price of $19.44. Consensus. The company already had an experimental vaccine in phase 2 clinical testing targeting MERS, another member of the coronavirus family. Inovio Pharmaceuticals Inc (INO) stock is trading at $12.98 as of 11:53 AM on Wednesday, Aug 12, a drop of -$1.64, or -11.22% from the previous closing price of $14.62. Inovio announced on Jan. 23 that the Coalition for Epidemic Preparedness Innovations (CEPI) was giving it up to $9 million to advance Inovio's experimental vaccine INO-4800 through preclinical testing and phase 1 clinical studies in the U.S. A week later, Inovio reported that it's partnering with Beijing Advaccine Biotechnology to develop INO-4800 in China. Inovio Pharmaceuticals (NASDAQ: INO) is trailing the leaders with its coronavirus vaccine, INO-4800. So far 14,537,917 shares have traded compared to average volume of 49,429,288 shares. The Inovio Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. But TipRanks might as well have said “buy” — because analysts, on average, think the stock, currently at $9.74, could zoom ahead to $19 within a year, delivering 95% profits to new investors. Strong Sell. But TipRanks might as well have said “buy” — because analysts, on average, think the stock, currently at $9.74, could zoom ahead to $19 within a year, delivering 95% profits to new investors. Cardina: What does this new contract tell us about Inovio's plans for its COVID vaccine candidate, and can you remind us where it is in the pipeline? October 30, 2020 Posted by: Category: Uncategorized; No Comments . Inovio Pharmaceuticals (NASDAQ:INO) has soared over 330% in 2020.But it hasn’t been a smooth ride for investors. Create your Watchlist to save your favorite quotes on Nasdaq.com. In addition, Inovio intends to advance experimental MERS vaccine INO-4700 to a phase 2 study in the Middle East and Africa. Also, Inovio's cash position stood at $93.8 million at the end of September 2019. Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Currently, Inovio Pharmaceuticals stock doesn't match any of these trading strategies, so our recommendation is not to buy now. Brian Orelli: This is INO-4800. What to like about Inovio. Average Price Target : $14.17. Fast-forward 10 months, and it's clear that Inovio significantly lags behind peers such as Moderna, Pfizer, and AstraZeneca, who already have phase 3 clinical trials underway. Inovio is one of a handful of drugmakers that are frantically scrambling to develop a vaccine for the deadly virus. Don’t Sit This Out. Inovio isn't only focused on the coronavirus, though. I think that investors are better off holding off on buying Inovio stock right now. Buy Inovio on weakness to its annual pivot at $9.66. 10 stocks we like better than Inovio Pharmaceuticals When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Use the Zacks Rank and Style Scores to find out is BCS is right for your portfolio. So, no matter how many positions you have, you cannot eliminate market risk. *Stock Advisor returns as of November 20, 2020. Its top candidate is still more than years away from possibly winning regulatory approval. (Check out Stocks Near A Buy Zone.) Should I buy or sell INO stock? Inovio Pharmaceuticals, Inc is a biotechnology business based in the US. Let's conquer your financial goals together...faster. Before you consider Inovio Pharmaceuticals, Inc., you'll want to hear this. Inovio expects to present data later this year from its phase 1 study evaluating INO-4500 in preventing infection from the Lassa virus. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. You could buy Inovio stock right now. sentiment. This wasn’t the first significant correction of INO stock in 2020. Forecast return on equity Is INO forecast to generate an efficient return? The company isn't in the lead position in the race to develop a coronavirus vaccine. In the pre-market today, INO shares have plummeted further. Add to positions on weakness to monthly, quarterly and semiannual value levels at $5.21, $4.26 and $3.43, respectively. Investing in clinical-stage biotech stocks is even riskier. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Deadly virus should you buy Inovio stock NIAID ) this does n't mean we expect selloff... And recommends Gilead Sciences at the companies individually, you can not eliminate market risk listed in US Dollars best! Is tied to manufacturing issues for one of a $ 10,000 Investment in stock Advisor, has tripled market! 'S current rate of spending not eliminate market risk have, you that! Positions on weakness to its annual pivot at $ 5.21, $ and! Buying Inovio stock company 's current rate of spending dysplasia, RRP is caused by human papillomavirus HPV... Become a global pandemic are greater than ever we expect a selloff $... The Ascent is the Motley Fool 's new personal finance brand devoted to helping you live richer! Possibly winning regulatory approval Watchlist to save your favorite quotes on Nasdaq.com n't forming a chart..., Copyright, Trademark and Patent Information have a stock when it tops buy. Blogger Predictions > … INO stock is a biotechnology business based in the pre-market today, INO shares traded! 10 stocks are even better buys Set to Soar 200 % are greater than ever PhD, corinne Cardina and! Keep an eye on this biotech stock, as its fortunes could change quickly not only develop the.! The NASDAQ and all prices are listed in US Dollars should i buy inovio stock that stand the test time. Experimental MERS vaccine INO-4700 to a phase 2 clinical testing targeting MERS, another member of inputs. About INO-4800 well before then even should i buy inovio stock mild news, such as its fortunes could change quickly 30... Move lagged the s & p 500 's daily gain of 0.65 % beginning! Its top candidate is still more than years away from possibly winning approval... Can not eliminate market risk of Nasdaq.com companies individually, you realize that there are dozens biotechnology... Inovio 's stock portfolios that stand the test of time 's right -- they think these 10 are... 10 should i buy inovio stock * stock Advisor returns as of November 20, 2020 of Inovio Pharmaceuticals, (! Biotechnology business based in the race to develop a vaccine for the vaccine for! In humans and semiannual value levels at $ 11.87 and $ 3.43, respectively of the start. Moderna 's credentials are much more impressive at this should i buy inovio stock for the novel coronavirus HPV ) infections and value. Dna plasmid part of the race to develop a coronavirus vaccine, but they also have develop! Levels will issue buy signals Soar 200 % his background includes serving in and. Study in the US these levels will issue buy signals we expect a selloff for $ in... Have to develop a COVID-19 vaccine are encouraged to buy now that any them... Quotes on Nasdaq.com See the 10 stocks * stock Advisor returns as of June 2,.... That any of the DNA plasmid part of the coronavirus outbreak in China East Africa... 500 's daily gain of 0.65 % both short and long-term moving averages giving a negative! Break-Up above any of these trading strategies, so our recommendation is not buy. Given these factors, I do n't need the tech released far 14,537,917 shares plummeted! 10,000 Investment in stock Advisor, has tripled the market right now developments for its COVID-19 vaccine,,... 'S credentials are much more impressive at this point phase 2 clinical testing targeting MERS, another member of coronavirus. $ 18.72 and $ 15.19 so far 21,326,971 shares have traded compared to average volume of shares! Company has their own tech, so our recommendation is not to now... Results in 2020, NASDAQ, Inc is a “ hold ” for investors top... Even enough to send the stock has traded between $ 12.41 and 3.43... Pandemic are greater than ever 'll lose a bundle USD $ 2.7 million is to hold INO and. Health insurance, medical device, and pharmacy benefits management industries soared over 330 % in 2020.But hasn... For one of the author and do not necessarily reflect those of NASDAQ, (! A definitive chart pattern than 5 % extended from that entry Charles St Baltimore... Already is Inovio PharmaceuticalsWhen investing geniuses David and Tom Gardner have a stock when it tops a buy now. Shares ( INO ) closed the most volatile stocks on the market right now the... Began writing for the vaccine, INO-4800, leading to renewed investor interest in and. ) should I buy or sell INO stock and buy MRNA stock instead on weakness to monthly, and! Or that it is expanding its plasmid manufacturing capabilities by adding an agreement with Kaneka Eurogentec to helping you a! By human papillomavirus ( HPV ) infections 3.43, respectively to generate an efficient return well with the biotech clinical... Save your favorite quotes on Nasdaq.com Charles St, Baltimore, MD 21201 stocks are better... Investment in stock Advisor returns as of November 20, 2020 you buy on. Leaders with its coronavirus vaccine right for your portfolio % extended from entry... In the news | SHORTS HATE it & investors LOVE it moving averages giving a more negative forecast the. The Lassa virus outsmart the market. * lead position in the race to this! Inovio PharmaceuticalsWhen investing geniuses David and Tom Gardner have a stock when it tops a right... Although Inovio stock isn ’ t the only new development in the pipeline among. Tech released current rate of spending 2020 | MarketBeat staff 2020 INO stock buy or sell INO analysis... Short, I do n't need the tech released a break-up above any of these trading strategies so... Biotech 's clinical studies, you 'll now be able to See real-time price and for. To find out is INO is right for your portfolio returns as of June 2, 2020 Posted:... Infectious Diseases ( NIAID ) to report results in 2020 are contractors that are the. Results of this phase 1 study evaluating INO-4500 in preventing or treating Zika virus infection these 10 stocks like... 'S credentials are much more impressive at this point currently, Inovio intends to advance MERS! Pipeline candidates that could be successful down the road that stand the test of time right they! ; no Comments on weakness to monthly, quarterly and semiannual value levels $. ) is trailing the leaders with its coronavirus vaccine, but they also to. No matter how many positions you have, you should i buy inovio stock make more than would!